Variables | LO-NEC onset | aβ/OR a (95% CI) 8 ~ 14d vs. 0d | aβ/OR a (95% CI) > 14d vs. 0d | aβ/OR a (95% CI) 8 ~ 14d vs. > 14d | ||
---|---|---|---|---|---|---|
LO-NEC occurring between 8 ~ 14d | LO-NEC occurring after 14d | non-LO-NEC | ||||
(n = 128) | (n = 84) | (n = 2297) | ||||
Early feeding | 65 (50.8) | 47 (56.0) | 1217 (53.0) | 0.42 (0.14 ~ 0.84) | 0.94 (0.47 ~ 2.89) | 0.28 (0.19 ~ 0.77) |
High proportion of breastfeeding | 27 (21.1) | 33 (39.3) | 1072 (46.7) | 0.25 (0.10 ~ 0.78) | 0.53 (0.08 ~ 0.89) | 0.37 (0.15 ~ 0.82) |
Fasting time | 7.8 (4.0,10.0) | 6.7 (4.5,8.0) | 1.5 (0.7,4.0) | -4.65 (− 6.02 ~ − 2.14) | -3.32 (− 5.18 ~ − 2.07) | -1.12 (− 7.88 ~ 2.55) |
Cumulative dose of MCT/LCT emulsion during W1 | 13.8 (10.2,15.9) | 12.6 (9.5,13.8) | 12.2 (9.7,14.7) | -3.44 (− 7.19 ~ − 1.16) | -2.07 (− 8.43 ~ 1.97) | -3.59 (− 6.45 ~ − 2.76) |
Gestational age | 29.8 (28.5,30.7) | 30.0 (28.8,30.9) | 30.1 (28.9,31.1) | -1.98 (− 5.64 ~ − 0.45) | -1.34 (− 6.78 ~ 4.96) | -1.47 (− 5.19 ~ 3.84) |
Grade III-IV NRDS | 24 (18.8) | 14 (16.7) | 336 (14.6) | 3.32 (1.76 ~ 6.45) | 2.11 (0.75 ~ 5.87) | 2.43 (0.68 ~ 7.54) |